OncoPharm

John Bossaer
  • 4.9 (174)
  • CIENCIA
  • CADA SEMANA
OncoPharm

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

  1. Revumenib

    HACE 3 DÍAS

    Revumenib

    The 1st menin inhibitor, revumenib, is approved for relapsed/refractory acute leukemias. Understanding the Pathway: https://doi.org/10.1200/JCO-24-01265

    15 min
  2. Anthracycline Use In Breast Cancer

    14 NOV

    Anthracycline Use In Breast Cancer

    A nice editorial succinctly summarizes a framework for thinking about how to incorporate anthracyclines into the treatment of early stage breast cancer patients. Anthracyclines in Early Breast Cancer: The Long Goodbye -https://doi.org/10.1200/JCO-24-01916 10-year Outcomes of READ trial: https://doi.org/10.1200/JCO.24.00836 Bonus - Practical Guide for Testing for Pharmacogenomics: https://doi.org/10.1200/OP.24.00191

    10 min
  3. SWISH

    7 NOV

    SWISH

    Reviewing the data to support use of dexamethasone solution mouthwash for PIK3/AKT/mTOR inhibitor-induced stomatitis, caused by drugs like everolimus, alpelisib, capivasertib, & inavolisib. SWISH: https://doi.org/10.1016/s1470-2045(17)30109-2 Alliance MIST Trial: https://doi.org/10.1053/j.seminoncol.2023.01.001

    9 min
  4. Zolbetuximab

    31 OCT

    Zolbetuximab

    The first Cldn 18.2 targeting monoclonal antibody has been improved. Let's talk about it!

    20 min
  5. S1826 & INTERLACE

    24 OCT

    S1826 & INTERLACE

    Discussing two excellent articles from earlier this month. S1826: N-AVD vs. Bv-AVD (DOI: 10.1056/NEJMoa2405888) & INTERLACE: induction chemo prior to concurrent cisplatin/RT in locally advanced cervical cancer (DOI: https://doi.org/10.1016/S0140-6736(24)01438-7)

    23 min
  6. Inavolisib

    17 OCT

    Inavolisib

    A new PIK3Ca inhibitor is approved for breast cancer.

    17 min
  7. Autumnal (2024) AML Updates

    10 OCT

    Autumnal (2024) AML Updates

    Reviewing 3 recent AML publications Double-Dauno (90 mg/m2 vs. 60 mg/m2): https://doi.org/10.1200/JCO.24.00235 AML60+ Risk Stratification: https://doi.org/10.1200/JCO.23.02631 Decitabine-Ven as bridge to Allo HSCT: https://doi.org/10.1016/S2352-3026(24)00241-2

    14 min
  8. MSI-High Rectal Cancer Treatment

    3 OCT

    MSI-High Rectal Cancer Treatment

    MSI-high/MMRd rectal cancer treatment guidelines are being re-written. A brief synopsis of why treatment guidelines are changing so quickly in this space. Also, listeners helped out in explaining the ribociclib storage & stability change. Hint: https://www.novartis.com/news/novartis-implements-manufacturing-adjustments-ribociclib-ensure-alignment-latest-regulatory-standards-ebc-end-q2

    10 min
Ver todo (355)

4.9
de 5
174 calificaciones

Acerca de

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

Información

  • Creador
    John Bossaer
  • Años de actividad
    2017 - 2024
  • Episodios
    355
  • Clasificación
    Apto
  • Copyright
    © All rights reserved
  • Mostrar sitio web
    OncoPharm

También te podría interesar

Para escuchar episodios explícitos, inicia sesión.

Mantente al día con este programa

Inicia sesión o regístrate para seguir programas, guardar episodios y enterarte de las últimas novedades.
Elige un país o región

Africa, Oriente Medio e India

Asia-Pacífico

Europa

Latinoamérica y el Caribe

Estados Unidos y Canadá